Featured Post

Personal Childhood Web

I want you all to know a little bit about my family. They are the ones who influenced, loved and nurtured me into who I am today. They are p...

Saturday, May 26, 2018

Research that Benefits Children and Families-Uplifting Stories


Research that Benefits Children and Families-Uplifting Stories
While reading this week’s resources and discussion posts, I realized that although some types of research are deemed risky, it is sometimes necessary in order to come up with desired, positive outcomes. I also felt most were only thinking of research in the early childhood field and not children in a broader sense. I feel that everyone has had a family member or a friend affected by cancer. I am sure I am not alone in this but cancer has seeped into my life in many ways. I became a warrior for cancer survivors many years ago when a close friend’s nephew was diagnosed with neuroblastoma. I followed his journey as his family fought for him every step of the way. They uprooted their family and moved to the east coast where he received treatment from a wonderful team of doctors at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. Through their research, clinical trials, and work with pediatric cancer, they have saved many lives. My friend’s nephew took part in clinical trials at MSKCC and in California not only to prolong and hopefully save his life, but to also aid in the development of better treatments for future pediatric cancer patients.  
I wanted to share his story because it is part of a happier story and it brings hope to children and their families who are fighting pediatric cancer. Jack was a friend of my friend’s nephew and they were receiving care from the same team at MSKCC at the same time. Due to clinical trials, this team of doctors was able to help Jack beat neuroblastoma. To further his success, Jack received a preventative vaccine and is now in remission (MSKCC, n.d.). This vaccine is called burtomab and was developed at MSKCC.  Burtomab was granted a Breakthrough Therapy Designation by the FDA. “The designation was given to the drug on the basis of a clinical study of 105 children with metastatic neuroblastoma who had all been treated at MSK since 2003. Those who received it in addition to conventional treatment with chemotherapy and radiation survived significantly longer than children who never received the drug. Celebrating the ten-year cancer-free milestone is now a reality for those first recruits” (MSKCC, 2017).
I wanted to share his story because it shows the need for research and clinical trials that are risky but necessary to improve the lives of others living with the same diagnosis. This breakthrough in cancer treatment would not have occurred without the clinical study of 105 children for the new drug, burtomab.
References
Memorial Sloan Kettering Cancer Center (MSKCC). (n.d.).  Jack’s Story. Retrieved from: https://www.mskcc.org/experience/hear-from-patients/jack
Memorial Sloan Kettering Cancer Center (MSKCC). (2017). FDA grants breakthrough therapy designation to burtomab for metastatic neuroblastoma. Retrieved from: https://www.mskcc.org/blog/fda-grants-breakthrough-therapy-designation-burtomab-metastatic-neuroblastoma

Saturday, May 19, 2018

My Personal Research Journey


My Personal Research Journey

            The topic I have chosen is discipline in school and how it impacts children in poverty and also its relationship to race. Black and Hispanic children are far more likely to be suspended or expelled than white children. I feel this is important because children who live in poverty also have many other factors that make them more disadvantaged than their peers. If we are going to close the “educational gap” for these children, then we will also have to take into consideration the harmful effects that harsh discipline such as Zero Tolerance that is mentioned in a review done by the American Psychological Association (and many other sources) has on our most disadvantaged youth. I became more aware of this dilemma through discovering and reading through the website Children’s Defense Fund. From looking through their site I found one of their campaigns called Cradle to Prison Pipeline campaign (Children’s Defense Fund, n.d.). Over 40 years ago, they published a report on this topic and we are still dealing with it today.
This week, I have searched and discovered more recent research and reports on this topic. I struggled at first to find reports that suited my needs. I was relieved to finally find three to write my literature review. I am sure I will feel more comfortable searching and summarizing literature reviews in the future. Part of what helped my search was remembering what I read in our text that almost all topics have been thought of so finding one related to what I am searching should not be difficult. “When looked at that way, almost no topic is so new or unique that you can’t locate a relevant and informative related research done previously” (Trochim, Donelly, & Arora 2016, p.11).
The research chart has really been a useful tool to construct. It is helping to solidify certain terms and parts of research that I was not familiar or comfortable with. Although I feel like this course will take more of my time and concentration, I also feel like it is giving me the chance to dive into a subject that piques my interest. 
If anyone has any resources, insights, or any other information regarding my topic or my blog, please leave a comment. I would love to hear from my colleagues!
Trish
References
American Psychological Association Zero Tolerance Task Force. (2008). Are zero tolerance policies effective in the schools? An evidentiary review and recommendations. American Psychologist 63(9), 852-862. Retrieved from: https://www.apa.org/pubs/info/reports/zero-tolerance.pdf
Children’s Defense Fund (n.d.). Cradle to prison pipeline. Retrieved from: http://www.childrensdefense.org/campaigns/cradle-to-prison-pipeline/
Trochim, W.M., Donelly, J.P., & Arora, K. (2016). Research Methods: The essential knowledge base (2nd ed.). Boston, MA: Cengage Learning.